摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(bromomethyl)-4(3H)-quinazolinone | 19062-51-2

中文名称
——
中文别名
——
英文名称
2-(bromomethyl)-4(3H)-quinazolinone
英文别名
2-(bromomethyl)quinazolin-4(3H)-one;2-(Bromomethyl)quinazolin-4(1h)-one;2-(bromomethyl)-3H-quinazolin-4-one
2-(bromomethyl)-4(3H)-quinazolinone化学式
CAS
19062-51-2
化学式
C9H7BrN2O
mdl
——
分子量
239.071
InChiKey
RWRLZXCEYLXJSO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >300 °C
  • 沸点:
    353.8±44.0 °C(Predicted)
  • 密度:
    1.71±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    41.5
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:8cd3d2c1dc1a4040a62fe3b34e1f685a
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    2-(bromomethyl)-4(3H)-quinazolinone 在 sodium azide 作用下, 以 丙酮 为溶剂, 反应 0.33h, 以97%的产率得到2-(azidomethyl)quinazolin-4(3H)-one
    参考文献:
    名称:
    Chemical Probes to Study ADP-Ribosylation: Synthesis and Biochemical Evaluation of Inhibitors of the Human ADP-Ribosyltransferase ARTD3/PARP3
    摘要:
    The racemic 3-(4-oxo-3,4-dihydroquinazolin-2-yl)-N-[1-(pyridin-2-yl)ethyl]propanamide, 1, has previously been identified as a potent but unselective inhibitor of diphtheria toxin-like ADP-ribosyltransferase 3 (ARTD3). Herein we describe synthesis and evaluation of SS compounds in this class. It was found that the stereochemistry is of great importance for both selectivity and potency and that substituents on the phenyl ring resulted in poor solubility. Certain variations at the meso position were tolerated and caused a large shift in the binding pose. Changes to the ethylene linker that connects the quinazolinone to the amide were also investigated but proved detrimental to binding. By combination of synthetic organic chemistry and structure-based design, two selective inhibitors of ARTD3 were discovered.
    DOI:
    10.1021/jm401394u
  • 作为产物:
    描述:
    2-甲基-4(3H)-喹唑酮N-溴代丁二酰亚胺(NBS) 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 24.0h, 以77%的产率得到2-(bromomethyl)-4(3H)-quinazolinone
    参考文献:
    名称:
    潜在的抗肿瘤药物在C2-位带有二硫代氨基甲酸酯侧链的喹唑啉-4(3 H)-one衍生物的合成及生物学评价
    摘要:
    合成了一系列在C2位带有二硫代氨基甲酸酯侧链的quinazolin-4(3 H)-one衍生物,并评估了其对A549,MCF-7,HeLa,HT29和HCT-116细胞系的抗增殖活性。大多数合成的化合物对五种细胞系均表现出广谱抗增殖活性,其中5c对HT29细胞系最有效,IC 50值为5.53μM,在HT29细胞中诱导了G2 / M期停滞。用5c处理HT29细胞会导致BubR1磷酸化,并以时间依赖性方式增加有丝分裂指数。此外,5c促进了微管蛋白的体外聚合。这些结果表明,在C2位带有二硫代氨基甲酸酯侧链的quinazolin-4(3 H)-one衍生物可能是靶向微管蛋白以激活纺锤体装配检查点的潜在新型抗肿瘤药。
    DOI:
    10.1016/j.ejmech.2015.11.044
点击查看最新优质反应信息

文献信息

  • Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
    申请人:Borchardt Allen
    公开号:US20050176701A1
    公开(公告)日:2005-08-11
    The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R 1 and R 2 , are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
    这项发明涉及公式1的化合物,以及其药学上可接受的盐、溶剂化合物、前药和代谢物,其中W、Z、R1和R2如本文所定义。该发明还涉及通过给哺乳动物施用公式1的化合物来治疗丙型肝炎病毒的方法,以及用于治疗这类疾病的含有公式1化合物的药物组合物。该发明还涉及制备公式1化合物的方法。
  • An efficient one-pot synthesis of functionally diverse 2-aminothiazoles from isothiocyanates, amidines/guanidines and halomethylenes
    作者:Hitesh B. Jalani、Amit N. Pandya、Dhaivat H. Pandya、Jayesh A. Sharma、V. Sudarsanam、Kamala K. Vasu
    DOI:10.1016/j.tetlet.2013.07.122
    日期:2013.9
    efficient one-pot method for the synthesis of 2-aminothiazoles using simple starting materials like isothiocyanates, amidines/guanidines and various halomethylenes is reported. The synthesis of 2-aminothiazoles involves reactions such as nucleophilic addition, S-alkylation and intramolecular nucleophilic substitution in which amines departs as the leaving group.
    报道了一种有效的一锅法,该方法使用诸如异硫氰酸酯,am /胍和各种卤代亚甲基之类的简单原料来合成2-氨基噻唑。2-氨基噻唑的合成涉及诸如亲核加成,S-烷基化和分子内亲核取代的反应,其中胺作为离去基团离开。
  • Synthesis of Chrysogine, a Metabolite of Penicillium chrysogenum and some related 2-substituted 4-(3H)-Quinazolinones
    作者:Jan Bergman、Anna Brynolf
    DOI:10.1016/s0040-4020(01)86694-1
    日期:1990.1
    Syntheses of both enantiomers of chrysogine, 2-(α-hydroxyethyl)-4(3H)-quinazolinone, 1 from 2-ammobenzamide are reported. Thus reaction of 2-aminobenzamide and optically active α-acetoxypropionyl chloride gave 9, which upon saponification and cyclization induced by aqueous sodium carbonate at room temperature gave chrysogine. The enantiomeric purity of 1 was determined by NMR. Inversion of (-)-(S)-1
    据报道,由2-氨苯甲酰胺合成了金葡胺的两种对映体2-(α-羟乙基)-4(3H)-喹唑啉酮1。因此,2-氨基苯甲酰胺与旋光性α-乙酰氧基丙酰氯的反应得到9,其在室温下由碳酸钠水溶液诱导的皂化和环化后得到金柳胺。通过NMR确定1的对映体纯度。使用Mitsunobo反应将(-)-(S)-1转化,得到(+)-(R)-1。的还原2 -乙酰基-4(3H)-qumazolinone 2与面包酵母,得到的S-对映体1。可以扩展使用的环化方法,并且还报道了许多2-(α-羟基)烷基-4-(3H)-喹唑啉酮。
  • Microwave Assisted Synthesis of Pyridin-1-ium Salt of 6-Nitroquinazolin-4-one and its 6-Amino Analog under Ultrasonic Irradiation
    作者:Hayun、A. Arrahman、H. Suryadi、A. Yanuar
    DOI:10.14233/ajchem.2014.16697
    日期:——
    The new compounds of quinazolin-4-one derivative i.e., 2-methyl-6-nitroquinazolin-4-one substituted pyridin-1-ium salt at methyl group and its 6-amino analog have been synthesized. Microwave irradiation of solution of 2-bromomethyl-6- nitroquinazolin-4-one and pyridine in acetonitrile for 3 min afforded 1-[(6-nitroquinazolin-4-one-2-yl)methyl]pyridin-1-ium bromide; and nitro reduction of the product
    合成了喹唑啉-4-酮衍生物的新化合物,即2-甲基-6-硝基喹唑啉-4-酮取代吡啶-1-鎓盐及其6-氨基类似物。2-溴甲基-6-硝基喹唑啉-4-酮和吡啶的乙腈溶液微波照射3分钟,得到1-[(6-硝基喹唑啉-4-one-2-yl)甲基]吡啶-1-鎓溴化物;在超声波照射下,产物在乙醇/乙酸/水中用铁进行硝基还原,得到 1-[(6-aminoquinazolin-4-one-2-yl)methyl]pyridin-1-ium bromide。基于FT-IR、1H NMR和13C NMR数据确认合成化合物的结构。
  • Mitotic kinesin inhibitors
    申请人:——
    公开号:US20040259826A1
    公开(公告)日:2004-12-23
    The present invention relates to quinazolinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
    本发明涉及喹唑啉酮化合物,用于治疗细胞增殖性疾病,治疗与KSP动力蛋白活性相关的疾病,并抑制KSP动力蛋白。本发明还涉及包含这些化合物的组合物,以及使用它们治疗哺乳动物癌症的方法。
查看更多